104 related articles for article (PubMed ID: 16816972)
1. Fascaplysin, a selective CDK4 inhibitor, exhibit anti-angiogenic activity in vitro and in vivo.
Lin J; Yan XJ; Chen HM
Cancer Chemother Pharmacol; 2007 Mar; 59(4):439-45. PubMed ID: 16816972
[TBL] [Abstract][Full Text] [Related]
2. Direct effects of fascaplysin on human umbilical vein endothelial cells attributing the anti-angiogenesis activity.
Zheng YL; Lu XL; Lin J; Chen HM; Yan XJ; Wang F; Xu WF
Biomed Pharmacother; 2010 Oct; 64(8):527-33. PubMed ID: 19932581
[TBL] [Abstract][Full Text] [Related]
3. Fascaplysin exert anti-tumor effects through apoptotic and anti-angiogenesis pathways in sarcoma mice model.
Yan X; Chen H; Lu X; Wang F; Xu W; Jin H; Zhu P
Eur J Pharm Sci; 2011 Jul; 43(4):251-9. PubMed ID: 21569843
[TBL] [Abstract][Full Text] [Related]
4. [In vitro anti-angiogenic action of lambda-carrageenan oligosaccharides].
Chen HM; Yan XJ; Wang F; Lin J; Xu WF
Yao Xue Xue Bao; 2007 Jun; 42(6):595-600. PubMed ID: 17702394
[TBL] [Abstract][Full Text] [Related]
5. Suppression of tumor-induced angiogenesis by taspine isolated from Radix et Rhizoma Leonticis and its mechanism of action in vitro.
Zhang Y; He L; Meng L; Luo W; Xu X
Cancer Lett; 2008 Apr; 262(1):103-13. PubMed ID: 18180095
[TBL] [Abstract][Full Text] [Related]
6. Preclinical anti-angiogenesis and anti-tumor activity of SIM010603, an oral, multi-targets receptor tyrosine kinases inhibitor.
Wang D; Tang F; Wang S; Jiang Z; Zhang L
Cancer Chemother Pharmacol; 2012 Jan; 69(1):173-83. PubMed ID: 21638122
[TBL] [Abstract][Full Text] [Related]
7. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.
Kunimasa K; Ikekita M; Sato M; Ohta T; Yamori Y; Ikeda M; Kuranuki S; Oikawa T
Cancer Sci; 2010 Nov; 101(11):2462-9. PubMed ID: 20670297
[TBL] [Abstract][Full Text] [Related]
8. Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis.
Thapa D; Lee JS; Heo SW; Lee YR; Kang KW; Kwak MK; Choi HG; Kim JA
Eur J Pharmacol; 2011 Jan; 650(1):64-71. PubMed ID: 20950604
[TBL] [Abstract][Full Text] [Related]
9. Total alkaloids of Rubus alceifolius Poir shows anti-angiogenic activity in vivo and in vitro.
Zhao J; Lin W; Zhuang Q; Zhong X; Cao Z; Hong Z; Peng J
Integr Cancer Ther; 2014 Nov; 13(6):520-8. PubMed ID: 25148840
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis.
Hseu YC; Wu CR; Chang HW; Kumar KJ; Lin MK; Chen CS; Cho HJ; Huang CY; Huang CY; Lee HZ; Hsieh WT; Chung JG; Wang HM; Yang HL
J Ethnopharmacol; 2011 Jun; 135(3):762-71. PubMed ID: 21515352
[TBL] [Abstract][Full Text] [Related]
11. Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4.
Chen S; Guan X; Wang LL; Li B; Sang XB; Liu Y; Zhao Y
Gene; 2017 Nov; 635():3-8. PubMed ID: 28888575
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
14. Effects of a Chinese herbal health formula, "Gan-Lu-Yin", on angiogenesis.
Pan CH; Hsieh IC; Liu FC; Hsieh WT; Sheu MJ; Koizumi A; Wu CH
J Agric Food Chem; 2010 Jul; 58(13):7685-92. PubMed ID: 20527984
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic function of tocotrienol.
Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
[TBL] [Abstract][Full Text] [Related]
17. [Anti-proliferation of human cervical cancer HeLa cell line by fascaplysin through apoptosis induction].
Lu XL; Zheng YL; Chen HM; Yan XJ; Wang F; Xu WF
Yao Xue Xue Bao; 2009 Sep; 44(9):980-6. PubMed ID: 20055172
[TBL] [Abstract][Full Text] [Related]
18. [Expression and biological activity of human angiogenesis inhibitor angiostatin in insect cells].
Xu XL; Liu GF; Huang DY
Ai Zheng; 2005 Sep; 24(9):1096-101. PubMed ID: 16159432
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells.
Tsai MY; Yang RC; Wu HT; Pang JH; Huang ST
Cancer Lett; 2011 Nov; 310(2):198-206. PubMed ID: 21788102
[TBL] [Abstract][Full Text] [Related]
20. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
